Philip Astley-sparke

chairman
pharmaceutical science
oxyrane
Belgium

Biography

Former President and Chief Executive Officer of BioVex until he sold the company to Amgen in 2011. Prior to Biovex, Mr. Astley-Sparke was an investment banker with Chase/Robert Fleming. Mr. Astley-Sparke is a chartered accountant and holds a BA in Cellular Pathology and Molecular Pathology from Bristol University (UK).

Research Interest

pathology molecular pathology virulence of microbiology

Global Experts from Belgium

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America